Ra Capital Management, L.P. Fulcrum Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,229,099 shares of FULC stock, worth $47.9 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
10,229,099
Previous 11,609,704
11.89%
Holding current value
$47.9 Million
Previous $72 Million
49.27%
% of portfolio
0.51%
Previous 1.08%
Shares
6 transactions
Others Institutions Holding FULC
# of Institutions
150Shares Held
52.2MCall Options Held
6.91MPut Options Held
1.9M-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$24.6 Million2.43% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$22.5 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$22.4 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$15.3 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$11 Million5.16% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $244M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...